“…BEC enhances the intrinsic ratio of Bax to Bcl-2 by up-regulating Bax and down-regulating Bcl-2 and Bcl-xL expressions. These effects result in activation of Caspase -8, -9 and -3 in cancer cells, indicating that BEC triggers extrinsic and intrinsic apoptotic pathways in cancer cells [6,[30][31][32][33][34][35][36][37].…”
Section: Bec5mentioning
confidence: 99%
“…Induction of apoptosis in cancer cells or malignant tissues is accepted as an efficient approach for cancer chemotherapy. Figure 3 shows that BEC rapidly kills cancer cells by the characteristic apoptotic pathway of cell shrinkage, condensation of chromatin and nuclear fragmentation [32,38].…”
Section: Bec5mentioning
confidence: 99%
“…BEC and its individual components solamargine and solasonine kill cancer cells in a dose-dependent manner and, at therapeutic doses, do not affect normal cells [5,32,34].…”
Section: Kill Cancer Cells Only and Not Normal Cellsmentioning
confidence: 99%
“…Ex Vivo studies have demonstrated that BEC is effecttive against a wide spectrum of human cancers and that BEC is, in a dose dependent manner, selectively killing cancer cells without harming normal cells [11][12][13][14][15][16]32,34,47,[49][50][51][52]. Figure 4 illustrates the specificity of BEC on cancer cells and lack of effect on normal cells.…”
Section: Kill Cancer Cells Only and Not Normal Cellsmentioning
“…BEC enhances the intrinsic ratio of Bax to Bcl-2 by up-regulating Bax and down-regulating Bcl-2 and Bcl-xL expressions. These effects result in activation of Caspase -8, -9 and -3 in cancer cells, indicating that BEC triggers extrinsic and intrinsic apoptotic pathways in cancer cells [6,[30][31][32][33][34][35][36][37].…”
Section: Bec5mentioning
confidence: 99%
“…Induction of apoptosis in cancer cells or malignant tissues is accepted as an efficient approach for cancer chemotherapy. Figure 3 shows that BEC rapidly kills cancer cells by the characteristic apoptotic pathway of cell shrinkage, condensation of chromatin and nuclear fragmentation [32,38].…”
Section: Bec5mentioning
confidence: 99%
“…BEC and its individual components solamargine and solasonine kill cancer cells in a dose-dependent manner and, at therapeutic doses, do not affect normal cells [5,32,34].…”
Section: Kill Cancer Cells Only and Not Normal Cellsmentioning
confidence: 99%
“…Ex Vivo studies have demonstrated that BEC is effecttive against a wide spectrum of human cancers and that BEC is, in a dose dependent manner, selectively killing cancer cells without harming normal cells [11][12][13][14][15][16]32,34,47,[49][50][51][52]. Figure 4 illustrates the specificity of BEC on cancer cells and lack of effect on normal cells.…”
Section: Kill Cancer Cells Only and Not Normal Cellsmentioning
“…Solasonina e solamargina são glicoalcaloides majoritários encontrados em pelo menos 100 espécies desse gênero (BLANKEMEYER et al, 1998). Estudos demonstraram ação citotóxica desses glicoalcaloides em diferentes linhagens de células tumorais humanas (ZHOU et al, 2014;DING et al, 2013;CHAM, CHASE, 2012;PUNJABI et al, 2008;KUO et al, 2000;DAUNTER, CHAM, 1990;CHAM et al, 1987). , 2008;LORENZI, 1992).…”
Section: Gênero Solanum E a Espécie Solanum Cernuum Vellozounclassified
An efficient synthesis of the steroidal alkaloids solasodine (1), O-acetylsolasodine (2), and soladulcidine (3) starting from easily available diosgenin and tigogenin in five or six steps (overall yield 25, 24, and 28%, resp.) is described. Moreover, our synthetic route provides a selective modification at C(3) of 1 and related compounds in order to carry out lead optimization on these natural antitumor steroidal alkaloids.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.